Cerebrolysin
Cerebrolysin is a mixture of low-molecular-weight neuropeptides and free amino acids derived from purified pig brain proteins. It is approved in many countries for stroke, traumatic brain injury, and dementia.
Mechanism of Action
Contains multiple neurotrophic factors that promote neuroplasticity, reduce neuronal apoptosis, and support synaptic function. Has both neurotrophic and neuroprotective properties.
Dosage Overview
Dose Range
2150 mg – 4300 mg
Route
intramuscular
Frequency
1x daily
Cycle Length
1–2 weeks
Reconstitution
Typical Dosage (Research)
Clinical dosing: 10-30ml IV daily for acute conditions. Research use: 5-10ml IM daily for cognitive enhancement. Treatment courses typically last 10-20 days.
Administered via intramuscular or intravenous injection. IV administration is typically used in clinical settings. IM can be used for research purposes.
Considerations for Men & Women
Women: Porcine brain-derived peptide mix used for cognitive disorders. Approved in some countries for stroke and dementia. No significant sex-specific dosing differences in clinical trials. Avoid during pregnancy.
Men: Same indications and dosing. Intramuscular or IV administration. Well-studied in elderly populations of both sexes.
Individual responses vary. These notes reflect general trends from research literature and are not medical advice.
Quick Calculator
Concentration: 215 mg/ml
Volume to inject: 10.00 ml
Syringe units (U-100): 1000.0 units
Pre-filled with Cerebrolysin defaults. Adjust values as needed.
Side Effects & Risks
Generally well-tolerated. May cause dizziness, headache, sweating, or injection site reactions. Rare cases of agitation or confusion.
Not FDA-approved in the US. Should be avoided in severe renal impairment and epilepsy. Quality and sourcing concerns outside clinical settings.
Who Uses Cerebrolysin
Stroke recovery patients, those with traumatic brain injury, individuals with cognitive decline, biohackers seeking neuroprotection.
Similar Peptides
View All Alternatives →Nicotinamide Adenine Dinucleotide (NAD+) is an essential coenzyme found in every living cell. It plays a central role in energy metabolism, DNA repair, gene expression, and cellular signaling. NAD+ levels naturally decline with age, and restoring them has become a major focus of longevity research. Injectable NAD+ bypasses the GI tract for higher bioavailability compared to oral precursors like NMN or NR.
Cortexin is a polypeptide complex derived from pig brain cortex, used clinically in Russia and Eastern Europe for neurological conditions including stroke recovery, traumatic brain injury, and cognitive decline.
Mod GRF 1-29 (Modified GRF 1-29, also called CJC-1295 without DAC or Tetrasubstituted GRF 1-29) is a modified growth hormone-releasing hormone analog with improved stability over natural GHRH.
Human Growth Hormone (somatropin) is a 191-amino acid protein identical to naturally produced GH. FDA-approved for growth hormone deficiency, Turner syndrome, and other conditions. Widely used off-label for anti-aging and performance.
MGF (Mechano Growth Factor) is a splice variant of IGF-1 that is produced locally in muscle tissue in response to mechanical stress. The non-PEGylated form has a very short half-life.